Longeveron Inc. (NASDAQ:LGVN) Short Interest Update

Longeveron Inc. (NASDAQ:LGVN) saw a large growth in short interest in April. As of April 15th, there was short interest totalling 91,100 shares, a growth of 224.2% from the March 31st total of 28,100 shares. Based on an average daily volume of 2,010,000 shares, the short-interest ratio is presently 0.0 days. Currently, 9.3% of the company’s stock are short sold.

Insider Buying and Selling at Longeveron

In other Longeveron news, Director Rock Soffer bought 31,915 shares of the business’s stock in a transaction dated Thursday, April 11th. The shares were acquired at an average price of $2.35 per share, with a total value of $75,000.25. Following the transaction, the director now owns 208,534 shares of the company’s stock, valued at $490,054.90. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. In other news, insider Joshua Hare purchased 106,383 shares of the business’s stock in a transaction on Wednesday, April 10th. The shares were bought at an average price of $2.35 per share, with a total value of $250,000.05. Following the completion of the transaction, the insider now directly owns 590,727 shares in the company, valued at approximately $1,388,208.45. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Rock Soffer purchased 31,915 shares of the business’s stock in a transaction on Thursday, April 11th. The shares were purchased at an average cost of $2.35 per share, for a total transaction of $75,000.25. Following the transaction, the director now owns 208,534 shares of the company’s stock, valued at $490,054.90. The disclosure for this purchase can be found here. Insiders have purchased 148,936 shares of company stock valued at $350,000 in the last quarter. Corporate insiders own 24.34% of the company’s stock.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Longeveron stock. Armistice Capital LLC bought a new stake in Longeveron Inc. (NASDAQ:LGVN) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 1,836,000 shares of the company’s stock, valued at approximately $2,497,000. Armistice Capital LLC owned about 7.31% of Longeveron at the end of the most recent quarter. Hedge funds and other institutional investors own 10.01% of the company’s stock.

Longeveron Trading Up 4.8 %

LGVN opened at $1.75 on Friday. The firm has a market cap of $4.40 million, a price-to-earnings ratio of -0.17 and a beta of 0.21. Longeveron has a 52 week low of $1.60 and a 52 week high of $44.00. The business’s 50 day moving average is $3.69 and its two-hundred day moving average is $11.00. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.21.

Longeveron (NASDAQ:LGVN) last released its quarterly earnings results on Tuesday, February 27th. The company reported ($2.50) EPS for the quarter, missing the consensus estimate of ($2.10) by ($0.40). The firm had revenue of $0.06 million for the quarter, compared to analyst estimates of $0.21 million. Longeveron had a negative return on equity of 209.14% and a negative net margin of 3,020.17%. On average, research analysts predict that Longeveron will post -8.5 EPS for the current year.

Longeveron Company Profile

Longeveron Inc, a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young, healthy adult donors.